Cargando…
High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases
INTRODUCTION: Hormone receptor (HR)-positive metastatic breast cancer (MBC) is usually treated with hormone therapy. In postmenopausal females, aromatase inhibitors (AIs) are usually used as first-line therapy, and fulvestrant is used subsequently. The optimal treatment beyond fulvestrant has not be...
Autores principales: | Mori, Ryutaro, Nagao, Yasuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086043/ https://www.ncbi.nlm.nih.gov/pubmed/25028579 http://dx.doi.org/10.1159/000363649 |
Ejemplares similares
-
Two Cases of Mastectomy after Paclitaxel + Bevacizumab Therapy for Locally Advanced Breast Cancer
por: Shinoda, Chika, et al.
Publicado: (2014) -
Epidermal Growth Factor Mutation as a Diagnostic and Therapeutic Target in Metastatic Poorly Differentiated Thyroid Carcinoma: A Case Report and Review of the Literature
por: Lote, Hazel, et al.
Publicado: (2014) -
Normoglycemic Diabetic Nephropathy: The Role of Insulin Resistance
por: Filippone, Edward J., et al.
Publicado: (2014) -
A Case of Plummer-Vinson Syndrome Showing Rapid Improvement of Dysphagia and Esophageal Web after Two Weeks of Iron Therapy
por: Tahara, Tomomitsu, et al.
Publicado: (2014) -
Toric Topographically Customized Transepithelial, Pulsed, Very High-Fluence, Higher Energy and Higher Riboflavin Concentration Collagen Cross-Linking in Keratoconus
por: Kanellopoulos, Anastasios John, et al.
Publicado: (2014)